Clinical Trials Directory

Trials / Unknown

UnknownNCT03083860

Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Brainmarc Ltd. · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Evaluation of migraine management mobile app combined with electrophysiological measurements for identification of migraine attack risk and beneficial preventive actions.

Conditions

Interventions

TypeNameDescription
DEVICEBEIBrainMARC Ltd. has demonstrated in recent years the ability to extract effective attention markers from averaged ERP waves sampled with a single EEG channel (two electrodes). In addition, BrainMARC has developed a template matching method to extract the attention-related markers at the single-trial level. An index (termed Brain Engagement Index - BEI) can then be generated from a 1-minute, single-channel sample.

Timeline

Start date
2017-09-01
Primary completion
2018-04-01
Completion
2018-12-01
First posted
2017-03-20
Last updated
2017-06-16

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT03083860. Inclusion in this directory is not an endorsement.

Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migra (NCT03083860) · Clinical Trials Directory